The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.

[1]  J. Foekens,et al.  Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma , 2013, Cell.

[2]  Roland Baron,et al.  WNT signaling in bone homeostasis and disease: from human mutations to treatments , 2013, Nature Medicine.

[3]  L. Chow,et al.  Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Brian Ell,et al.  SnapShot: Bone Metastasis , 2012, Cell.

[5]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[6]  P. Wysocki,et al.  Progress in the treatment of bone metastases in cancer patients , 2012, Expert opinion on investigational drugs.

[7]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[8]  J. Schneider,et al.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. , 2012, Cancer research.

[9]  Fanxin Long,et al.  Building strong bones: molecular regulation of the osteoblast lineage , 2011, Nature Reviews Molecular Cell Biology.

[10]  J. Massagué,et al.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. , 2011, Cancer cell.

[11]  M. Ott,et al.  E–N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells , 2011, The Journal of cell biology.

[12]  K. Shokat,et al.  The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile , 2011, Proceedings of the National Academy of Sciences.

[13]  T. Guise,et al.  TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases , 2011, Cancer Microenvironment.

[14]  Jason I. Herschkowitz,et al.  Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells , 2011, Proceedings of the National Academy of Sciences.

[15]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[16]  Jiannis Ragoussis,et al.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization , 2011, Nature Medicine.

[17]  E. Fuchs,et al.  Ferreting out stem cells from their niches , 2011, Nature Cell Biology.

[18]  K. Pienta,et al.  Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.

[19]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[20]  G. Dontu,et al.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.

[21]  G. Hortobagyi,et al.  Future directions of bone-targeted therapy for metastatic breast cancer , 2010, Nature Reviews Clinical Oncology.

[22]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Shokat,et al.  Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. , 2010, Cancer cell.

[24]  Yi Zhang,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone , 2010, Nature Protocols.

[25]  J. Chirgwin,et al.  Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment , 2009, PloS one.

[26]  I. Holen,et al.  Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples , 2009, Clinical & Experimental Metastasis.

[27]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[28]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[29]  F. Saad,et al.  Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference , 2008, Clinical Cancer Research.

[30]  John W M Martens,et al.  Subtypes of breast cancer show preferential site of relapse. , 2008, Cancer research.

[31]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[32]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[33]  P. Gascón,et al.  Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  U. Landegren,et al.  Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.

[35]  T. Golub,et al.  Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.

[36]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[37]  Shiuan Chen,et al.  Dual Inhibition of mTOR and Estrogen Receptor Signaling In vitro Induces Cell Death in Models of Breast Cancer , 2005, Clinical Cancer Research.

[38]  T. Guise,et al.  Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy , 2005, Journal of Mammary Gland Biology and Neoplasia.

[39]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[40]  C. Restall,et al.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. , 2005, Molecular cancer research : MCR.

[41]  Jiang Shou,et al.  Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance , 2004, Clinical Cancer Research.

[42]  M. Tomasson,et al.  Platelet and osteoclast β3 integrins are critical for bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[44]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[45]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[46]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[48]  K. Johnson,et al.  Mechanism of extracellular domain-deleted dominant negative cadherins. , 1999, Journal of cell science.

[49]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[50]  D. Wallwiener,et al.  Reduction in new metastases in breast cancer with adjuvant clodronate treatment. , 1998, The New England journal of medicine.

[51]  S. Robinson,et al.  Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse. , 1989, Cancer research.

[52]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[53]  J. Thigpen.  Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer , 2012 .

[54]  K. Pantel,et al.  Cancer micrometastases , 2009, Nature Reviews Clinical Oncology.

[55]  R. Reger,et al.  Differentiation and characterization of human MSCs. , 2008, Methods in molecular biology.

[56]  G. Stein,et al.  The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. , 1995, Experimental cell research.